Melanoma is one of the most common cancers in the West, and the research arena is bustling; advances in immunotherapy and genomics are reflected in the increasing survival of patients. This Primer summarizes these developments and discusses the challenges ahead.
- Dirk Schadendorf
- David E. Fisher
- Axel Hauschild